Stockreport

Can Fite Received Approval for COVID-19 Clinical Trial in Israel, Patient Enrollment and Dosing to Commence Immediately

Can-Fite Biopharma Ltd Sponsored ADR (Israel)  (CANF) 
NASDAQ:AMEX Investor Relations: ir.canfite.com
PDF Study will treat 40 COVID-19 infected patients hospitalized with moderate-to-severe symptomsEfficacy endpoints include viral shedding and resolution of symptoms PETAC [Read more]